首页> 外文期刊>International Journal of Clinical and Experimental Pathology >Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection
【24h】

Diagnostic value of MCM2 immunocytochemical staining in cervical lesions and its relationship with HPV infection

机译:MCM2免疫细胞化学染色在宫颈病变中的诊断价值及其与HPV感染的关系

获取原文
           

摘要

Cervical cancer remains the fourth most common cause of cancer-related deaths in women worldwide, and human papillomavirus infection represents the most important risk factor for the development of cervical cancer. Minichromosome maintenance protein-2 has been previously identified by DNA microarray and transcriptional profiling as genes that is overexpressed in cervical carcinomas. 183 cases were enrolled and tested with thin prep liquid-based cytology test. The expressions of human papillomavirus were detected and minichromosome maintenance protein-2 immuncytochemical test was performed on liquid-based pap smears from the samples. Those results were compared with the cervical histopathology results. The positive expression rates of minichromosome maintenance protein-2 and high-risk type human papillomavirus increased with the severity of cervical lesions. The expression level of MCM2 was positively correlated with high-risk types of human papillomavirus. In cervical carcinoma and precancerous lesions, minichromosome maintenance protein-2 was overexpressed and positively correlated with the high risk types of human papillomavirus. As minichromosome maintenance protein-2 immuncytochemical detection was better than genotyping of human papillomavirus, minichromosome maintenance protein-2 may serve as a useful marker in the screening of cervical carcinoma and precancerous lesions and improve the diagnosis of atypical squamous cell of undetermined significance. The joint application can improve the sensitivity and specificity of diagnosis.
机译:宫颈癌仍然是全世界女性与癌症相关的死亡的第四大最常见原因,而人类乳头瘤病毒感染是宫颈癌发展的最重要风险因素。以前,微染色体维持蛋白2已通过DNA微阵列和转录谱鉴定为在宫颈癌中过表达的基因。 183例患者入选并进行了薄型基于液体的细胞学检查。检测人乳头瘤病毒的表达,并对样品中的液基宫颈涂片进行微染色体维持蛋白2免疫细胞化学测试。将这些结果与宫颈组织病理学结果进行比较。微小染色体维持蛋白2和高危型人乳头瘤病毒的阳性表达率随宫颈病变的严重程度而增加。 MCM2的表达水平与高危型人乳头瘤病毒呈正相关。在宫颈癌和癌前病变中,微染色体维持蛋白2过度表达,并与高危型人乳头瘤病毒呈正相关。由于微染色体维持蛋白2的免疫细胞化学检测优于人乳头瘤病毒的基因分型,因此微染色体维持蛋白2可以作为筛查宫颈癌和癌前病变的有用标志物,并提高对非典型鳞状细胞的诊断的意义。联合应用可以提高诊断的敏感性和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号